Testing effectiveness (Phase 2)Study completedNCT00004256
What this trial is testing
Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer
Who this might be right for
Head and Neck CancerOral ComplicationsRadiation Toxicity
Royal Marsden NHS Foundation Trust